The global chondroitin market is projected to amass a revenue of about USD 1.6 billion by 2032, up from USD 1.2 billion in 2022 moving forward with a CAGR of 2.8% during the forecast period (2022 to 2032).
The rising prevalence of obesity, as well as increased product demand from the veterinary sector, is expected to push the demand for chondroitin forward.
The sales of chondroitin are also likely to spike owing to rising usage in pharmaceutical applications and rising consumer spending power on personal care products.
| Report Attribute | Details |
|---|---|
| Chondroitin Market Value (2022) | USD 1.2 Billion |
| Chondroitin Market Anticipated Forecast Value (2032) | USD 1.6 Billion |
| Chondroitin Market Projected Growth Rate (2022 to 2032) | 2.8% |
Chondroitin is a component of the human body in the bones and cartilage. It is also popularly called as chondroitin sulfate and the rising sales of chondroitin are majorly due to its use in the dietary supplements used for osteoarthritis.
Chondroitin sold on a commercial basis is obtained from the cartilages of various sources such as marine, bovine, avian, chicken, and cow. The shark cartilage is known to be the best chondroitin source leading to an uptick in overall demand for chondroitin.
The demand for chondroitin in the form of capsules is also on the surge as it is mostly utilized in households.
The rising sales of chondroitin in powder form can be attributed to its usage in the pharmaceuticals and the industries that use chondroitin as an ingredient as a whole or in combination with other chemicals or drugs.
Consumption of chondroitin sulfate in nutraceutical applications is anticipated to gain traction as dietary supplements gain acceptance, in turn, enlarges the chondroitin market share.
The rise in the number of joint pain cases is also projected to create a conducive environment for the growth of demand for chondroitin in tandem with sales of chondroitin.
Since chondroitin is widely used to treat pets with joint pain and arthritis, including diseases like chronic pain and aches from elbow dysplasia, hip dysplasia, and osteoarthritis, the sales of chondroitin, on the whole, are likely to surge.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Chondroitin along with other ingredients such as glucosamine is being used in dietary supplements due to its various health benefits thereby soaring the demand for chondroitin.
The rising sales of chondroitin can also be attributed to its use in the treatment of osteoarthritis and its popularity including its treatment of various other problems as well.
Chondroitin is being used in drugs for heart problems, breast cancer, interstitial cystitis, psoriasis, and many other diseases and the demand for chondroitin is expected to even move further as it is also being used to treat anemia in complex with iron.
These benefits have led to the increased use of chondroitin in dietary supplements, in turn, swaying the chondroitin market share on the whole.
The use of chondroitin is not only limited to nutraceuticals but is also being used as a pharmaceutical drug along with others, opening up a wide array of chondroitin market opportunities.
Its usage as an eye drop and receipt of approval for the same by the FDA is auguring well for the chondroitin market share.
The sales of chondroitin are also influenced by the use of the same in the cosmetics industry, though it is very less as it is expected to grow in the upcoming years.
The production is mainly carried out in the Asia Pacific especially in China, where the demand for chondroitin has been on a higher trajectory.
On account of the fact that consumption of chondroitin is more in the USA, the chondroitin market share in the region is likely to expand and all the chondroitin that is consumed in the USA is imported from overseas.
Chondroitin-containing supplements are one of the top five best-selling dietary supplements globally, in turn, soaring the sales of chondroitin around the globe.
Since the use of chondroitin as a dietary supplement is expected to increase in South and East Asia in the upcoming years, the demand for chondroitin is also likely to go up in those regions.
The demand for chondroitin as well as sales of chondroitin is significantly fuelled by its usage in cosmetics and personal care products in Europe and the Middle East and Africa.
The sales of chondroitin also take place by various different names one of them being chondroitin sulfate which is very popular.
Principal Consultant
Some of the key players in the chondroitin market include TSI Group Ltd., Synutra Pure, Ltd., Bioiberica S.A.U., Kala Health Inc., Shanghai Jbichem International Trading Co. Ltd., Summit Nutritionals International, Inc., Pacific Rainbow International, Inc.
Qingdao Kangyuan Pharmaceutical, Beloorbayir Biotech Ltd., AdvaCare Pharma, Sichuan Biosyn Pharmaceutical Co., Ltd., Inter Farma, Jiaxing Hengjie Bio-pharmaceutical LLC, Seikagaku Corporation are some other players in the market.
Many chondroitin manufacturers sell dietary supplements and their label indicates the presence of chondroitin in them but the quantity of chondroitin is as little as 10% which results in low-quality products.
However, in order to augment their chondroitin market share, many manufacturers are trying to clean up the supply chain of chondroitin sulfate.
One of such recent developments in the chondroitin market is when Synutra Ingredients is using gel electrophoresis to stop adulteration of chondroitin and is one of the leading manufacturers of chondroitin in the USA.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 2.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2014 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Method, Application, End Use, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASIAN, GCC Countries, South Africa |
| Key Companies Profiled | TSI Group Ltd.; Synutra Pure, Ltd.; Bioiberica S.A.U.; Kala Health Inc.; Shanghai Jbichem International Trading Co. Ltd.; Summit Nutritionals; International, Inc.; Pacific Rainbow International, Inc.; Qingdao Kangyuan Pharmaceutical; Beloorbayir Biotech Ltd.; AdvaCare Pharma; Sichuan Biosyn Pharmaceutical Co., Ltd.; Inter Farma; Jiaxing Hengjie Bio-pharmaceutical LLC; Seikagaku Corporation |
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global chondroitin market is set to advance at a CAGR of 2.8% from 2022 to 2032.
Chondroitin along with other ingredients such as glucosamine is being used in dietary supplements due to its various health benefits thereby soaring the demand for chondroitin.
Some of the key players in the global chondroitin market are TSI Group Ltd., Synutra Pure, Ltd., Bioiberica S.A.U., Kala Health Inc., and Shanghai Jbichem International Trading Co. Ltd.
1. Executive Summary | Chondroitin Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Source 5.1. Marine 5.2. Bovine 5.3. Avian 5.4. Other Sources 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Form 6.1. Powder 6.2. Capsules 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Grade 7.1. Pharmaceutical Grade 7.2. Industrial Grade 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 8.1. Sports Nutrition 8.2. Pharmaceuticals 8.3. Dietary Supplements 8.4. Cosmetics and Personal Care 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel 9.1. Direct Sales 9.2. Indirect Sales 9.2.1. Drug Stores 9.2.2. Pharmacies 9.2.3. Online Retail 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. Asia Pacific 10.5. Middle East and Africa 11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. TSI Group Ltd. 18.2. Synutra Pure, Ltd. 18.3. Bioiberica S.A.U. 18.4. Kala Health Inc. 18.5. Shanghai Jbichem International Trading Co. Ltd. 18.6. Summit Nutritionals International, Inc. 18.7. Pacific Rainbow International, Inc. 18.8. Qingdao Kangyuan Pharmaceutical 18.9. Beloorbayir Biotech Ltd. 18.10. AdvaCare Pharma 18.11. Sichuan Biosyn Pharmaceutical Co., Ltd. 18.12. Inter Farma 18.13. Jiaxing Hengjie Bio-pharmaceutical LLC 18.14. Seikagaku Corporation 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Chondroitin Market
